![Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains | ACS Chemical Biology Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains | ACS Chemical Biology](https://pubs.acs.org/cms/10.1021/cb4003283/asset/images/medium/cb-2013-003283_0006.gif)
Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains | ACS Chemical Biology
![Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease | ACS Chemical Neuroscience Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.0c00363/asset/images/large/cn0c00363_0009.jpeg)
Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease | ACS Chemical Neuroscience
![A signature of enhanced lipid metabolism, lipid peroxidation and aldehyde stress in therapy-induced senescence | Cell Death Discovery A signature of enhanced lipid metabolism, lipid peroxidation and aldehyde stress in therapy-induced senescence | Cell Death Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fcddiscovery.2017.75/MediaObjects/41420_2017_Article_BFcddiscovery201775_Fig1_HTML.jpg)
A signature of enhanced lipid metabolism, lipid peroxidation and aldehyde stress in therapy-induced senescence | Cell Death Discovery
![Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease | ACS Chemical Neuroscience Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.0c00363/asset/images/large/cn0c00363_0004.jpeg)